共 209 条
[1]
Maude SL(2014)Chimeric antigen receptor T cells for sustained remissions in leukemia New Engl J Med 371 1507-1517
[2]
Frey N(2016)CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients J Clin Invest 126 2123-2138
[3]
Shaw PA(2017)Axicabtagene Ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma New Engl J Med. 377 2531-2544
[4]
Aplenc R(2010)Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 Blood. 116 4099-4102
[5]
Barrett DM(2012)B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells Blood. 119 2709-2720
[6]
Bunin NJ(2006)Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience J Clin Oncol 24 e20-e22
[7]
Turtle CJ(2010)Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 Mol Ther 18 843-851
[8]
Hanafi L(2013)Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells Nat Biotechnol 31 71-75
[9]
Berger C(2017)Masked chimeric antigen receptor for tumor-specific activation Mol Ther 25 274-284
[10]
Gooley TA(2016)Precision tumor recognition by T cells with combinatorial antigen-sensing circuits Cell 164 770-779